Einträge von Kreuzer, Karl-Anton auf dem Publikationsserver

Braess, Jan, Amler, Susanne, Kreuzer, Karl-Anton, Spiekermann, Karsten, Lindemann, Hans Walter, Lengfelder, Eva, Graeven, Ullrich, Staib, Peter, Ludwig, Wolf-Dieter, Biersack, Harald, Ko, Yon-Dschun, Uppenkamp, Michael J., De Wit, Maike, Korsten, Stefan, Peceny, Rudolf, Gaska, Tobias, Schiel, Xaver, Behringer, Dirk M., Kiehl, Michael G., Zinngrebe, Bettina, Meckenstock, Gerald, Roemer, Eva, Medgenberg, Dirk, Spaeth-Schwalbe, Ernst, Massenkeil, Gero, Hindahl, Heidrun, Schwerdtfeger, Rainer, Trenn, Guido, Sauerland, Cristina, Koch, Raphael, Lablans, Martin, Faldum, Andreas, Görlich, Dennis, Bohlander, Stefan K., Schneider, Stephanie, Dufour, Annika, Buske, Christian, Fiegl, Michael, Subklewe, Marion, Braess, Birgit, Unterhalt, Michael, Baumgartner, Anja, Wörmann, Bernhard, Beelen, Dietrich und Hiddemann, Wolfgang (2018) Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study. Leukemia 32 (12), S. 2558-2571. Volltext nicht vorhanden.

Lengfelder, Eva, Görlich, Dennis, Nowak, Daniel, Spiekermann, Karsten, Haferlach, Claudia, Krug, Utz, Kreuzer, Karl-Anton, Braess, Jan, Schliemann, Christoph, Lindemann, Hans-Walter, Horst, Heinz A., Schiel, Xaver, Flasshove, Michael, Hecht, Anna, Schnittger, Susanne, Schneider, Stephanie, Wörmann, Bernhard, Hofmann, Wolf-Karsten, Berdel, Wolfgang E., Bormann, Eike, Sauerland, Cristina, Büchner, Thomas und Hiddemann, Wolfgang (2017) Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines. European Journal of Haematology 100 (2), S. 154-162. Volltext nicht vorhanden.

Mills, Ken, Pohlen, Michele, Thoennissen, Nils H., Braess, Jan, Thudium, Johannes, Schmid, Christoph, Kochanek, Matthias, Kreuzer, Karl-Anton, Lebiedz, Pia, Görlich, Dennis, Gerth, Hans U., Rohde, Christian, Kessler, Torsten, Müller-Tidow, Carsten, Stelljes, Matthias, Büchner, Thomas, Schlimok, Günter, Hallek, Michael, Waltenberger, Johannes, Hiddemann, Wolfgang, Berdel, Wolfgang E., Heilmeier, Bernhard und Krug, Utz (2016) Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction. PLOS ONE 11 (8), e0160871. Volltext nicht vorhanden.

Serve, Hubert , Krug, Utz, Wagner, Ruth, Sauerland, M. Cristina, Heinecke, Achim, Brunnberg, Uta, Schaich, Markus, Ottmann, Oliver , Duyster, Justus, Wandt, Hannes, Fischer, Thomas, Giagounidis, Aristoteles, Neubauer, Andreas, Reichle, Albrecht, Aulitzky, Walter, Noppeney, Richard, Blau, Igor, Kunzmann, Volker, Stuhlmann, Reingard, Krämer, Alwin, Kreuzer, Karl-Anton, Brandts, Christian , Steffen, Björn, Thiede, Christian , Müller-Tidow, Carsten, Ehninger, Gerhard und Berdel, Wolfgang E. (2013) Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial. Journal of Clinical Oncology 31 (25), S. 3110-3118. Volltext nicht vorhanden.

Gökbuget, Nicola, Stanze, Daniel, Beck, Joachim, Diedrich, Helmut, Horst, Heinz-August, Hüttmann, Andreas, Kobbe, Guido, Kreuzer, Karl-Anton, Leimer, Lothar, Reichle, Albrecht, Schaich, Markus, Schwartz, Stefan, Serve, Hubert , Starck, Michael, Stelljes, Matthias, Stuhlmann, Reingard, Viardot, Andreas, Wendelin, Knut, Freund, Mathias und Hoelzer, Dieter (2012) Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood 120 (10), S. 2032-2041. Volltext nicht vorhanden.

Pfeifer, Heike, Goekbuget, Nicola, Völp, Christian, Hüttmann, Andreas, Lübbert, Michael, Stuhlmann, Reingard, Dengler, Julanta, Kreuzer, Karl-Anton, Beck, Joachim, Stelljes, Matthias, Schmid, Mathias, Wassmann, B., Leimer, Lothar, Spiekermann, Karsten, Terwey, Theis H, Schäfer-Eckart, K., Ditz, D., Lindemann, H., Morgner, A., Schaich, Markus, Burmeister, Thomas, Binckebanck, A., Hoelzer, Dieter und Ottmann, Oliver G. (2010) Long-Term Outcome of 335 Adult Patients Receiving Different Schedules of Imatinib and Chemotherapy as Front-Line Treatment for Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL). Blood 116 (21), S. 173. Volltext nicht vorhanden.

Serve, Hubert, Wagner, Ruth, Sauerland, Cristina, Brunnberg, Uta, Krug, Utz, Schaich, Markus, Ottmann, Oliver G. , Duyster, Justus, Wandt, Hannes, Herr, Wolfgang, Giagounidis, Aristoteles A.N., Neubauer, Andreas, Reichle, Albrecht, Aulitzky, Walter E., Noppeney, Richard, Blau, Igor Wolfgang, Kunzmann, Volker, Schmitz, Norbert, Kreuzer, Karl-Anton, Krämer, Alwin, Brandts, Christian, Steffen, Björn, Heinecke, Achim, Thiede, Christian, Müller-Tidow, Carsten, Ehninger, Gerhard und Berdel, Wolfgang E. (2010) Sorafenib In Combination with Standard Induction and Consolidation Therapy In Elderly AML Patients: Results From a Randomized, Placebo-Controlled Phase II Trial. Blood 116 (21), S. 333. Volltext nicht vorhanden.